Discovery and Mediclinic scale back plans for vaccine sites amid supply concerns
The companies put brakes on new sites as only 1.3-million Pfizer doses delivered
Discovery and Mediclinic, two of the country’s key private sector operators, have put the brakes on plans to expand their coronavirus vaccination sites, as concern grows over looming supply constraints...
Would you like to comment on this article?
Register (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
This article is reserved for DispatchLIVE subscribers.
Get access to ALL DispatchLIVE content from only R49.00 per month.
Already subscribed? Simply sign in below.
Already registered on HeraldLIVE, BusinessLIVE, TimesLIVE or SowetanLIVE? Sign in with the same details.
Questions or problems? Email helpdesk@dispatchlive.co.za or call 0860 52 52 00.